Infectious Diseases News and Research

RSS

Janssen seeks European marketing approval for combination of once-daily darunavir with cobicistat

Janssen-Cilag International NV, today announced it has submitted a Marketing Authorisation Application to the European Medicines Agency seeking approval for a once-daily single tablet fixed-dose antiretroviral combination product containing darunavir, a protease inhibitor developed by Janssen, with cobicistat, a pharmacokinetic enhancer or boosting agent, developed by Gilead Sciences, Inc. for use in combination with other human immunodeficiency virus medicines.

15 Oct 2013

Study explores why girls in minority groups, low-income families don't get HPV vaccine

A new study explores why girls in minority groups and low-income families, who are most at risk for cervical cancer, may not be getting the human papillomavirus or HPV vaccine.

15 Oct 2013

Research finding may help patients to better survive severe infectious diseases

Scientists of Charité - Universitätsmedizin Berlin for the first time have solved the 3-dimensional structure of the protein LBP and it´s genetic variant. This finding may help certain patients to better survive severe infectious diseases. The results have been published in the recent issue of the journal Immunity.

15 Oct 2013

Football-shaped artificial particles teach immune cells to recognize, destroy cancer cells

Researchers at Johns Hopkins have succeeded in making flattened, football-shaped artificial particles that impersonate immune cells. These football-shaped particles seem to be better than the typical basketball-shaped particles at teaching immune cells to recognize and destroy cancer cells in mice.

14 Oct 2013

Researchers discover new approach to tackle global threat of antibiotic drug resistance

Researchers at McMaster University are addressing the crisis in drug resistance with a novel approach to find new antibiotics.

13 Oct 2013

NIH selects Salk scientist for EUREKA grant

The National Institutes of Health has selected Axel Nimmerjahn for a highly competitive EUREKA (Exceptional Unconventional Research Enabling Knowledge Acceleration) grant. Dr. Nimmerjahn is an Assistant Professor in the Waitt Advanced Biophotonics Center and holds the Richard Allan Barry Developmental Chair.

13 Oct 2013

Scientists decode key molecular gateway for toxin that causes botulism

U.S. and German scientists have decoded a key molecular gateway for the toxin that causes botulism, pointing the way to treatments that can keep the food-borne poison out of the bloodstream.

12 Oct 2013

UTHealth professor receives Oswald Avery Award for Early Achievement from IDSA

Cesar Arias, M.D., Ph.D., associate professor in the Division of Infectious Diseases at The University of Texas Health Science Center at Houston Medical School, was bestowed the Oswald Avery Award for Early Achievement from the Infectious Diseases Society of America.

12 Oct 2013

Evidence shows vaccination pilot campaigns highly successful during 2010 cholera epidemic

The deadly cholera epidemic that rocked earthquake-shattered Haiti in 2010, claiming 8,000 lives and counting, has rallied the public health community to seek water and sewer improvements that, combined with vaccination, could prevent some 89,000 future cholera infections.

11 Oct 2013

Patients who received care at multiple HIV clinics have higher HIV viral loads

Patients who received care at multiple HIV clinics—as opposed to only one— were less likely to take their medication and had higher HIV viral loads, a new study published in the journal AIDS and Behavior of almost 13,000 HIV patients in Philadelphia from Penn Medicine found.

10 Oct 2013

Receiving care at several HIV clinics may increase medication errors

Patients who received care at multiple HIV clinics-as opposed to only one- were less likely to take their medication and had higher HIV viral loads, a new study published in the journal AIDS and Behavior of almost 13,000 HIV patients in Philadelphia from Penn Medicine found.

10 Oct 2013

Gov't shutdown triggered by Capitol Hill causes damage to public health

The Centers for Disease Control and Prevention calls in furloughed scientists after a salmonella outbreak in California sickened people in 18 states.

10 Oct 2013

Researchers recently launched Collaborative Hepatitis Network in Africa

Although it does not receive as much attention as AIDS, hepatitis has long been one of Africa's most serious health problems.

9 Oct 2013

Salk scientist receives Career Development Award for new research from JDRF

The Juvenile Diabetes Research Foundation has given Salk scientist Mark Huising a five-year, $750,000 Career Development Award for his proposed study on how a novel network of receptors in human islets receives and integrates molecular signals. In pre-clinical models, activation of these receptors has proven to actually prevent diabetes.

9 Oct 2013

Janssen buys all rights from GSK to develop, commercialize hepatitis C compound

Janssen Pharmaceuticals, Inc. announced today the acquisition of the investigational compound GSK2336805, an NS5a replication complex inhibitor in Phase 2 development for the treatment of chronic hepatitis C, from an affiliate of GlaxoSmithKline plc.

9 Oct 2013

Researchers to develop effective mucosal vaccines based on cell-targeted nanoparticles

The Knut and Alice Wallenberg Foundation will give a little over SEK 16 million to the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Professor Nils Lycke at MIVAC at the Sahlgrenska Academy will in cooperation with researchers at Chalmers University of Technology and Lund University, combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.

9 Oct 2013

FMCNA encourages dialysis patients to get vaccinated against flu

With early cases of seasonal flu already being reported in the U.S., Fresenius Medical Care North America (FMCNA), the nation's leading network of dialysis facilities, is strongly encouraging dialysis patients to get flu shots to protect themselves against this common infectious disease.

9 Oct 2013

Boehringer Ingelheim’s interim data from Phase II HCV clinical collaboration with Presidio Pharmaceuticals accepted for presentation at AASLD

Boehringer Ingelheim today announced that interim data from its Phase II hepatitis C (HCV) clinical collaboration with Presidio Pharmaceuticals have been accepted for presentation as a late breaker poster at the 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), taking place 1-5 November in Washington, D.C. (1) The poster presentation will be on Monday 4 November.

8 Oct 2013

Researcher receives 2013 Victoria Prize for contributions in quest to eradicate malaria

Malaria researcher Professor Alan Cowman from the Walter and Eliza Hall Institute has been awarded the 2013 Victoria Prize for Science and Innovation in recognition of his outstanding contributions in the quest to eradicate malaria.

8 Oct 2013

Scientists to highlight Bio-Rad's Droplet Digital PCR applications at CHI Digital PCR Conference

Since its introduction in 2011, Bio-Rad Laboratory's Droplet Digital PCR (ddPCR-) technology has demonstrated the potential to be a transformative technology, particularly in clinical applications.

8 Oct 2013

Infectious Diseases News and Research

Janssen seeks European marketing approval for combination of once-daily darunavir with cobicistat

Study explores why girls in minority groups, low-income families don't get HPV vaccine

Research finding may help patients to better survive severe infectious diseases

Football-shaped artificial particles teach immune cells to recognize, destroy cancer cells

Researchers discover new approach to tackle global threat of antibiotic drug resistance

NIH selects Salk scientist for EUREKA grant

Scientists decode key molecular gateway for toxin that causes botulism

UTHealth professor receives Oswald Avery Award for Early Achievement from IDSA

Evidence shows vaccination pilot campaigns highly successful during 2010 cholera epidemic

Patients who received care at multiple HIV clinics have higher HIV viral loads

Receiving care at several HIV clinics may increase medication errors

Gov't shutdown triggered by Capitol Hill causes damage to public health

Researchers recently launched Collaborative Hepatitis Network in Africa

Salk scientist receives Career Development Award for new research from JDRF

Janssen buys all rights from GSK to develop, commercialize hepatitis C compound

Researchers to develop effective mucosal vaccines based on cell-targeted nanoparticles

FMCNA encourages dialysis patients to get vaccinated against flu

Boehringer Ingelheim’s interim data from Phase II HCV clinical collaboration with Presidio Pharmaceuticals accepted for presentation at AASLD

Researcher receives 2013 Victoria Prize for contributions in quest to eradicate malaria

Scientists to highlight Bio-Rad's Droplet Digital PCR applications at CHI Digital PCR Conference

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News